Plavix sales in April are staggering

Published: 2010-05-24 06:58:00

Updated: 2010-05-24 06:58:00

Sanofi-Aventis’s blood thinner Plavix posted 45.5 billion won in April this year, down 5.7 percent compared with 48.2 billion won during the same period of last year, according to Ubist.

Other drug makers producing the generic version of Plavix have been plagued by loss of sales.

The sluggi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK